Bristol-Myers Changes DTC Ad Policy

How can you keep pace with an accelerating marketing ecosystem? Join us at Brandweek Sept. 12–16 in Miami alongside leading CMOs, founders and change makers from GatoradeMarriottAlo YogaCampbell'sUncommon James and more. Book now.

BOSTON Bristol-Myers Squibb said it would cease advertising drugs directly to consumers during their first year on the market.

The client spent $140 million on paid media in 2004, per Nielsen Monitor-Plus.

“For a minimum of 12 months following a launch of a new medication, Bristol-Myers Squibb will refrain from any direct-to-consumer branded mass media [television, radio and print] advertising to promote the medication,” the client said in a “DTC Communications Code” posted on its Web site.

AW+

WORK SMARTER - LEARN, GROW AND BE INSPIRED.

Subscribe today!

To Read the Full Story Become an Adweek+ Subscriber

View Subscription Options

Already a member? Sign in